Research carried out in the Tommy’s National Centre for Miscarriage Research suggests that giving progesterone to pregnant women with early pregnancy bleeding and a history of miscarriage could increase their chances of having a baby.
The PRISM trial, funded by the National Institute for Health Research (NIHR) and co-ordinated in the University of Birmingham in collaboration with Tommy’s National Centre for Miscarriage Research, is the largest ever trial of its kind and involved 4,153 pregnant women who presented with early pregnancy bleeding.
The women, being treated at 48 hospitals across the UK and with the average age of 31, were randomly assigned by computer into one of two groups – one group of 2,079 women were given progesterone, while the other group of 2,074 women were given a placebo.
Dr Adam Devall, Senior Clinical Trial Fellow at the University of Birmingham and Manager of Tommy’s National Centre for Miscarriage Research, explained: “Miscarriage is a common complication of pregnancy, affecting 1 in 5 women, and vaginal bleeding in early pregnancy is associated with a 1 in 3 risk of miscarriage.
“Several small studies have suggested that administering progesterone, a hormone essential for maintaining a pregnancy, may reduce the risk of miscarriage in women presenting with early pregnancy bleeding.
“The PRISM trial was undertaken to answer a very important research question; whether progesterone given to pregnant women with threatened miscarriage would increase the number of babies born after at least 34 weeks of gestation when compared with a placebo.”
Benefit applies to those with previous history of miscarriage
While the research did not show statistically strong enough evidence to suggest that progesterone could help all women who are suffering early pregnancy bleeding to go on to have a baby, importantly the results did show the hormone benefited those who had early pregnancy bleeding and had previously suffered a miscarriage.
What did the results show?
The results showed that although the treatment did not reduce the rate of miscarriage for those with no previous miscarriages, there was a small reduction in miscarriage for those with 1-2 previous miscarriages and a big reduction in miscarriage for those with 3 or more previous miscarriages.
The overall live birth rate was 75% (1513/2025) in the progesterone group and 72% (1459/2013) in the placebo group. That 3% difference in live birth was not ‘statistically significant’ – meaning that the difference could have been due to chance.
However, when the results were split by the number of previous miscarriages that the participants had suffered, the analysis showed that:
- No previous miscarriages: the live birth rate was 74% (824/1111) in the progesterone group and 75% (840/1127) in the placebo group, ie no benefit
- 1-2 previous miscarriages: the live birth rate was 76% (591/777) in the progesterone group and 72% (534/738) in the placebo group, ie some benefit
- 3 or more previous miscarriages: the live birth rate was 72% (98/137) in the progesterone group and 57% (85/148) in the placebo group, ie substantial benefit
The ground-breaking research was published today in the New England Journal of Medicine.
The role of progesterone uncertain for years
Arri Coomarasamy, Professor of Gynaecology at the University of Birmingham and Director of Tommy’s National Centre for Miscarriage Research, said: “The role of progesterone in women with early pregnancy bleeding has been studied and debated for about 60 years, however what we have previously lacked is high quality evidence.
“The largest study before the PRISM trial had less than 200 participants; whereas our study had more than 4,000 participants and was of very high quality, which means we can be confident in our findings.
“Our finding that women who are at risk of a miscarriage because of current pregnancy bleeding and a history of a previous miscarriage could benefit from progesterone treatment has huge implications for practice. This treatment could save thousands of babies who may have otherwise been lost to a miscarriage.
“We hope that this evidence will be considered by the National Institute for Health and Care Excellence (NICE) and that it will be used to update national guidelines for women at risk of miscarriage.”
Jane Brewin, Chief Executive of Tommy’s, said: “The results from this study are important for parents who have experienced miscarriage; they now have a robust and effective treatment option which will save many lives and prevent much heartache.
“It gives us confidence to believe that further research will yield more treatments and ultimately make many more miscarriages preventable.”
I have early pregnancy bleeding. Where can I get this treatment?
If you have early pregnancy bleeding and have suffered one or more previous miscarriages you should request progesterone treatment. As many clinicians will not have heard of this very recent research we have developed a simple and clear infographic that you can bring with you to the doctor that clearly explains the benefits of the treatment.
Get our research updates
Tommy's funds research across the UK investigating the reasons for pregnancy complications and loss. We can keep you updated on our research news. If you're interested in being kept updated about our research and news from Tommy's, click here.
Miscarriage and ectopic pregnancy may trigger long-term post-traumatic stress, anxiety and depression
The largest ever study into the psychological impact of miscarriage and ectopic pregnancy has shown that early-stage pregnancy loss can have a serious impact on mental health. The research was led by Professor Tom Bourne at the Tommy’s National Centre for Miscarriage Research at Imperial College London.
A pilot trial led by Tommy’s National Centre for Miscarriage Research suggests diabetes drug could be repurposed to target the lining of the womb in women with recurrent miscarriage.
More than a third of maternity doctors admitted they suffer from burnout and exhaustion. This means that they may avoid difficult cases, over-prescribe medications and care less about their patients, increasing the risk of mistakes.
Abdominal stitch is more effective than vaginal stitch for women who experience recurrent preterm births
A clinical trial has shown that an abdominal stitch can save babies’ lives by reducing preterm birth for high-risk women who have had a previous failed vaginal stitch. The trial was led and co-authored by Professor Andrew Shennan, Clinical Director of Tommy’s Preterm Surveillance Clinic.
“I was a broken mess and I felt like my grief was wrong because it wasn’t a real baby, like I was being dramatic, over-the-top.”
Toni and her husband Matt had a miscarriage in 2015 which left Toni with PTSD. The couple live in Leicester with daughters Phoebe and Willow. This is Toni's story.
Roslyn and Paul from South Ayrshire in Scotland had an early miscarriage before getting pregnant with their first daughter Ava who is now 4 years old. They went on to lose another 3 babies before getting a referral to Tommy’s National Centre for Miscarriage Research at University Hospital in Coventry. Their second daughter, Ciara, was born in April 2019 and is now 7 months old.
Kirsty and Paul from Preston had 3 miscarriages before they were referred to the Tommy’s National Centre for Miscarriage Research at Birmingham Women’s Hospital. In January 2019, Kirsty gave birth to Alice Ivy.
Katie sadly lost two babies before falling pregnant with her third child. In this piece, Katie speaks of the heartbreak she faced, and reflects on her road to recovery.
Holly and Peter, who experienced recurrent miscarriage, had a missed miscarriage before becoming pregnant with their daughter Millie, who is now 4 years old. In 2017, they found out they were expecting again but sadly lost their baby, Sophie, at 14 weeks. After another 2 missed miscarriages, their second rainbow baby Finley arrived.
After Rebecca and Lee from Bedfordshire had 2 heart-breaking miscarriages, the learnt they were not eligible for specialist miscarriage care unless they’d lost 3 babies. Rebecca is now 16 weeks pregnant and reflects on her journey.
Danielle from Peterborough had had 3 recurrent miscarriages before being referred to the Tommy’s National Centre for Miscarriage Research. Whilst undergoing treatment, she lost another 2 babies before becoming pregnant for the sixth time. Danielle and her fiancé Ed are currently 21 weeks pregnant and their baby is due in March in 2020. This is Danielle’s story.
I felt an overwhelming rush of sadness: sadness for the loss of my first grandchild and sadness that my own baby was going through so much pain.
Anne from North Wales reflects on how she supported her daughter who had a missed miscarriage at 12 weeks.
By Fellicia (not verified) on 12 Dec 2019 - 08:27
You are doing amazing work! Thanks for sharing your wonderful posts! Progesterone (Prometrium) saved my baby. I was showing signs of miscarrying because of my hormone levels (due to insufficient progesterone levels). So happy I found “Get365prg” in Google and got Prometrium, I took Prometrium (progesterone) for 12 weeks. The bleeding stopped the next day and I now have a healthy little boy! It is pretty commonly prescribed for low progesterone levels to help avoid miscarriage until the placenta takes over progesterone production.
By Zain (not verified) on 16 Jul 2019 - 20:53
Hello, I have suffered 3 miscarriages and I was wondering if progesterone is available on South Africa and can my doctor prescribe it.
By Katie (not verified) on 7 Jul 2019 - 16:00
What does the progesterone trial mean for women who have had missed miscarriages with no vaginal bleeding? Does this mean women should take progesterone at the start of pregnancy to prevent miscarriage? Can anyone give any advice?
By alex (not verified) on 23 May 2019 - 16:13
don't know if im pregnant?